Psoriasis and HIV infection

International Journal of Dermatology

Volumn 35, Issue 7, 1996, Pages 475-479

  Montazeri, Ashraf ^b   Kanitakis, Jean ^a   Bazex, Jacques ^b  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ANTIPSORIASIS AGENT; CIMETIDINE; CIPROFLOXACIN; ETRETINATE; IMMUNOSUPPRESSIVE AGENT; KETOCONAZOLE; METHOTREXATE; PENICILLIN G; RIFAMPICIN; ZIDOVUDINE;

ARTHRALGIA; BRAIN DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; HEADACHE; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION; LEUKOPENIA; LIVER TOXICITY; PATHOGENESIS; PHOTOTHERAPY; PROGNOSIS; PSORIASIS; PUVA; REVIEW; ULTRAVIOLET B RADIATION;

EID: 0030035896     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-4362.1996.tb01658.x     Document Type: Review

References (51)

1. Keet IP, Krijnen P, Koot M, et al. Predictors of rapid progression to AIDS in HIV-1 seroconverters. AIDS 1993; 7:51-57.
2. Bournerias I. Atteintes cutanées au cours de l'infection par le VIH. In: Montagnier L, Rozenbaum W, Gluckman JC, eds. AIDS et infection par le VIH. Paris: Flammarion Médecine-Sciences, 1989:251-263.
3. Goodman DS, Teplits ED, Wishner A, et al. Prevalence of cutaneous disease in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex. J Am Acad Dermatol 1987; 17:210-220.
4. Sainte-Marie D, Pradinaud R, Cassiede P. Manifestations dermatologiques et vénéréologiques observées dans le SIDA en Guyane française. Nouv Dermatol 1988; 7:419-424.
5. Bundy T, Simjee S, Ray M, et al. Psoriatic patient presenting with perioral herpetiform lesions. Arch Dermatol 1989; 125:1440-1441.
6. Marchand C, Thivolet J. Signes cutanéo-muqueux de l'infection VIH. Nouv Dermatol 1990; 9:141-142.
7. Janier M, Reynaud B, Gerbaka J, et al. Signes cutanés de l'infection par le VIH: Étude prospective de 267 patients. Ann Dermatol Vénéréol 1994; 121:S46-S48.
8. Fisher BK, Warner LC, Matlow AG. Cutaneous manifestations of the acquired immunodeficiency syndrome. In: Parish LC, ed. Sexually transmitted diseases. New York: Springer-Verlag, 1989:284-313.
9. Bousquet R. Manifestations cutanéo-muqueuses dans l'infection à VIH (à l'exception des tumeurs): le point de vue du dermatologue. Nouv Dermatol 1990; 6:517-518.
10. Cockerell C. Cutaneous manifestations of HIV infection. J Am Acad Dermatol 1990; 22:1306-1318.
11. Duvic M, Johnson TM, Rapini RP, et al. Acquired immunodeficiency syndrome-associated psoriasis and Reiter's syndrome. Arch Dermatol 1987; 123:1622-1632.
12. Sadick NS, McNutt NS, Kaplan MH. Papulosquamous dermatoses of AIDS. J Am Acad Dermatol 1990; 22: 1270-1277.
13. Bournerias I. Psoriasis and HIV. In: Dubertret L, ed. Psoriasis. Brescia: ISED, 1994:265-270.
14. Camp RDR. Psoriasis. In: Champion R, Burton JL, Ebling FJG, eds. Textbook of dermatology. London: Blackwell Scientific, 1992:1391-1457.
15. Obuch ML, Maurer TA, Becker B, et al. Psoriasis and human immunodeficiency virus infection. J Am Acad Dermatol 1992; 27:667-763.
16. Smith KJ, Skelton HG, Yeager J, et al. Cutaneous findings in HIV-1-positive patients: a 42-month prospective study. J Am Acad Dermatol 1994; 31:746-754.
17. Lazar A, Roenigk H. AIDS and psoriasis. Cutis 1987; 39:347-351.
18. Penneys N. Skin manifestations of AIDS. London: Martin Dunitz, 1995:174-182.
19. Lin RY. Reiter's syndrome and human immunodeficiency virus infection. Dermatologica 1988; 176:39-42.
20. Zukervar P, Vigneaud H, Hill M, et al. SIDA et psoriasis acropustuleux: amélioration sous étrétinte (Tigason). Nouv Dermatol 1990; 9:212-213.
21. Chaker M, Cockerell C. Concomitant psoriasis, seborrheic dermatitis, and disseminated cutaneous histoplasmosis in a patient infected with human immunodeficiency virus. J Am Acad Dermatol 1993; 29:311-313.
22. Dover J, Johnson R. Cutaneous manifestations of human immunodeficiency virus infection. Arch Dermatol 1991; 127:1549-1558.
23. Friedman-Kien A, Harte J. American Academy of Dermatology symposium on AIDS. J Am Acad Dermatol 1991; 25:1086-1091.
24. Espinoza L, Jara L, Espinoza C, et al. There is an association between human immunodeficiency virus infection and spondyloarthropathies. Rheum Dis Clin North Am 1992; 18:257-266.
25. Daniel C, Norton L, Scher R. The spectrum of nail disease in patients with human immunodeficiency virus infection. J Am Acad Dermatol 1992; 27:93-97.
26. Grinspan D, Fernandez Blanco G, Aguero S, et al. Ectopic geographic tongue and AIDS. Int J Dermatol 1990; 29:113-116.
27. Van Neer F, Zemelman V, Cerio R, et al. The role of factor XIIIa-positive dermal dendrocytes in HIV-1-positive psoriatics. Br J Dermatol 1993; 128:29-33.
28. McNutt S, Hsu A, Sadick N, et al. Psoriasiform dermatitis of AIDS. J Cutan Pathol 1989; 16:317. [Abstr]
29. Horn T, Herzberg G, Hood A. Characterization of the dermal infiltrate in human immunodeficiency virus-infected patients with psoriasis. Arch Dermatol 1990; 125:1462-1465.
30. Smith K, Skelton H, Angritt P. Changes of verruciform xanthoma in an HIV-1+ patient with diffuse psoriasiform skin disease. Am J Dermatopathol 1995; 17:185-188.
31. Duvic M. Immunology of AIDS related to psoriasis. J Invest Dermatol 1990; 95:38s-40s.
32. Smith K, Skelton H, Wagner K. Pathogenesis of HIV-1 disease. Int J Dermatol 1995; 34:308-318.
33. Sheppard HW, Ascher MS, McRae B, et al. The initial immune response to HIV and immune system activation determine the outcome of HIV disease. J Acquir Immune Defic Syndr 1992; 4:704-712.
34. Dezube BJ, Pardee AB, Beckette LA, et al. Cytokine dysregulation in AIDS: in vivo overexpression of mRNA of tumor necrosis factor-alpha and its correlation with that of the inflammatory cytokine (GRO). J Acquir Immune Defic Syndr 1992; 5:1099-1104.
35. Fuchs D, Sepp S, Susanne B, et al. Immune activation and psoriasis. Lancet 1991; ii:759. (Letter)
36. Smoller C, McNutt S, Gray M, et al. Detection of the interferon-gamma-induced protein 10 in psoriasiform dermatitis of acquired immunodeficiency syndrome. Arch Dermatol 1990; 126:1457-1461.
37. Zemelman V, Van Neer F, Roberts N, et al. Epidermal Langerhans cells, HIV-1 infection and psoriasis. Br J Dermatol 1994; 130:307-311.
38. Jaffe D, Pete May L, Sanchez M, et al. Staphylococcal sepsis in HIV antibody seropositive psoriasis patients. J Am Acad Dermatol 1991; 24:970-972.
39. Lazar A, Roenigk H. Acquired immunodeficiency syndrome (AIDS) can exacerbate psoriasis. J Am Acad Dermatol 1988; 18:144.
40. Johnson T, Duvic M, Rapini R, et al. AIDS exacerbates psoriasis. N Engl J Med 1985; 313:1415.
41. Kazerouni-Meunier F, Picard-Dahan C, Descamps V, et al. Induction d'un psoriasis pustuleux par le G-CSF chez un patient atteint de SIDA. Ann Dermatol Vénéréol 1994; 121:9s-10s.
42. Colebunders R, Blot K, Mertens V, et al. Psoriasis regression in terminal AIDS. Lancet 1992; i:1110.
43. Williams C, du Vivier A. Etretinate and AIDS-related Reiter's disease. Br J Dermatol 1991; 124:389-392.
44. Ranki A, Puska P, Mattinen S, et al. Effect of PUVA on immunologic and virologic findings in HIV-infected patients. J Am Acad Dermatol 1991; 24:404-410.
45. Rosenberg EW, Skinner RB, Noah PW, et al. AIDS and psoriasis. Int J Dermatol 1991; 30:449.
46. Kaplan MH, Sadick NS, Wieder J, et al. Antipsoriatic effects of zidovudine in human immunodeficiency virus-associated psoriasis. J Am Acad Dermatol 1989; 20:76-82.
47. Duvic M, Rios A, Brewton GW. Remission of AIDS-associated psoriasis with zidovudine. Lancet 1987; ii:627.
48. Diez F, Del Hoyo M, Serrano S. Zidovudine treatment of psoriasis associated with acquired immunodeficiency syndrome. J Am Acad Dermatol 1990; 22:146-147.
49. Ruzicka T, Fröschl M, Hohenleutner U, et al. Treatment of HIV-induced retinoid-resistant psoriasis with zidovudine. Lancet 1987; ii:1469-1470.
50. Bonnekoh B, Wevers A, Geisel J, et al. Antiproliferative potential of zidovudine in human keratinocyte cultures. J Am Acad Dermatol 1991; 25:483-490.
51. Strashower ME, Yeager JK, Smith KJ, et al. Cimetidine as therapy for treatment-resistant psoriasis in a patient with acquired immunodeficiency syndrome. Arch Dermatol 1993; 129:848-850.